These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 30844790

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H, Liu J, Yue D, Gao L, Wang D, Zhang H, Wang C.
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O, Linares E, Tilki D, Capitanio U, Evans CP, Montorsi F, Martínez-Salamanca JI, Libertino J, Gontero P, Palou J.
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [Abstract] [Full Text] [Related]

  • 6. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.
    Zhang X, Yang M, Shi H, Hu J, Wang Y, Sun Z, Xu S.
    Oncotarget; 2017 Mar 21; 8(12):19566-19576. PubMed ID: 28223537
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
    Xu L, Jiang Y, Zheng J, Xie G, Li J, Shi L, Fan S.
    Hum Pathol; 2013 Jul 21; 44(7):1357-64. PubMed ID: 23375645
    [Abstract] [Full Text] [Related]

  • 9. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X, Li S, Xu Z, Wang K, Fu D, Liu Q, Wang X, Wu B.
    World J Surg Oncol; 2015 Feb 04; 13():14. PubMed ID: 25650039
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.
    Tsuji Y, Goto A, Hara I, Ataka K, Yamashita C, Okita Y, Kamidono S.
    J Vasc Surg; 2001 Apr 04; 33(4):789-96. PubMed ID: 11296333
    [Abstract] [Full Text] [Related]

  • 12. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R, Roscigno M, Freschi M, Strada E, Angiolilli D, Petralia G, Matloob R, Sozzi F, Capitanio U, Da Pozzo LF, Colombo R, Guazzoni G, Cremonini A, Montorsi F, Rigatti P.
    Eur Urol; 2011 Aug 04; 60(2):358-65. PubMed ID: 21640483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?
    Choi DK, Jeon HG, Jeong CW, Kwak C, Song C, Chung J, Hong SK, Hong SH, Seo SI, Korean Renal Cancer Study Group.
    Int J Urol; 2017 Feb 04; 24(2):102-109. PubMed ID: 28111837
    [Abstract] [Full Text] [Related]

  • 15. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.
    Eur Urol; 2014 Sep 04; 66(3):577-83. PubMed ID: 23871402
    [Abstract] [Full Text] [Related]

  • 16. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu N, Lan F, Liu Y, Yan S, Dong X, Cai L.
    Cancer Epidemiol; 2013 Dec 04; 37(6):985-92. PubMed ID: 24012693
    [Abstract] [Full Text] [Related]

  • 17. Tumor thrombus of inferior vena cava in patients with renal cell carcinoma - clinical and oncological outcome of 50 patients after surgery.
    Vergho DC, Loeser A, Kocot A, Spahn M, Riedmiller H.
    BMC Res Notes; 2012 Jun 01; 5():5. PubMed ID: 22658129
    [Abstract] [Full Text] [Related]

  • 18. Natural history of untreated renal cell carcinoma with venous tumor thrombus.
    Reese AC, Whitson JM, Meng MV.
    Urol Oncol; 2013 Oct 01; 31(7):1305-9. PubMed ID: 22237466
    [Abstract] [Full Text] [Related]

  • 19. Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
    Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A, International Renal Cell Carcinoma-Venous Thrombus Consortium, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D, Wallen EM, Zigeuner R.
    J Surg Oncol; 2016 Nov 01; 114(6):764-768. PubMed ID: 27562252
    [Abstract] [Full Text] [Related]

  • 20. Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines.
    Bodnar L, Stec R, Cierniak S, Synowiec A, Wcisło G, Jesiotr M, Koktysz R, Chrom P, Szczylik C.
    Clin Genitourin Cancer; 2018 Aug 01; 16(4):257-265. PubMed ID: 29483043
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.